Press release
Depression Drugs Market: Popularity of Tech-based Mental Health Apps also Contributing to Low Sales || Key Players: Sebela Pharmaceutical Inc., GlaxoSmithKline plc, AstraZeneca plc, Eli Lilly and Company, Allergan USA, Inc
Request Free Sample Report Here:
https://www.factmr.com/connectus/sample?flag=S&rep_id=3215
According to the World Health Organization (WHO), depression has become one of the common illnesses, affecting over 300 million people across the world. In the United States, approximately 10.3 million adults had experienced at least one major depressive episode that resulted in severe impairment, according to the National Institute of Mental Health (NIMH). High prevalence of such depressive episode was observed among people aged 18-25 (10.9%), female adults (8.5%), and male adults (4.8%). According to the Fact.MR study, although depression continues to be a major health issue, medical community and patients are encouraging a non-drug approach to reduce side effects and dependency. Healthcare providers and patients are focusing on cognitive behavior therapy (CBT) and mindfulness-based approaches to foster a long-term management of depression and other mental health issues.
Browse Full report on Market with TOC:
https://www.factmr.com/report/3215/depression-drugs-market
Depression Drugs Market: Segment-wise Insights
On the basis of drug class, the global depression drugs market has been segmented into SSRIs, atypical antipsychotics, SNRIs, CNS stimulants, and others. Of these, atypical antipsychotics is expected to contribute the largest share in the market.
Major depressive disorder has been envisaged to account for the most substantial share in the depression drugs market based on disease type. Other sub-segments include SSRI induced, schizophrenia, and bipolar I disorder.
While depression drugs are sold across retail, hospital, and online pharmacies, the retail segment registered the largest share in 2017, and the trend is expected to continue during the 2018-2026 period.
Fact.MR offers accurate data depending on supply side, demand side, and dynamics of the global depression drugs market. This comprehensive study encompasses market forecast in terms of revenue (US$ Mn). This in-depth study also offers stats on Year-on-Year (Y-o-Y) growth of the depression drugs market. Key information about the depression drugs market share is drawn through regional pricing trends. Market size and forecast for each section have been incorporated in terms of the global and regional depression drugs markets. The market has been weighed based on the robust demand determinants. The values used for calculating the market size are obtained through primary researches carried out by setting up interviews with a number of manufacturers, distributors, and suppliers of the depression drugs market.
Global Depression Drugs Market: Competitive Landscape
Some key players operating in the manufacturing of depression drugs are Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson, Sebela Pharmaceutical Inc., GlaxoSmithKline plc, AstraZeneca plc, Eli Lilly and Company, Allergan USA, Inc., Takeda Pharmaceutical Company Ltd, Novartis AG, Pfizer, Inc., Alkermes Plc, H. Lundbeck, Bristol Myers Squibb Co., and Teva Pharmaceutical Industries Ltd.
Have Any Query?? Ask Our Industry Expert:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=3215
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
sales@factmr.com
www.factmr.com
Read Full PR Here:
https://www.factmr.com/media-release/935/depression-drugs-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Depression Drugs Market: Popularity of Tech-based Mental Health Apps also Contributing to Low Sales || Key Players: Sebela Pharmaceutical Inc., GlaxoSmithKline plc, AstraZeneca plc, Eli Lilly and Company, Allergan USA, Inc here
News-ID: 1693326 • Views: …
More Releases from Fact.MR
Premium Beauty and Personal Care Products Market Anticipates US$ 780.16 Billion …
The Premium Beauty and Personal Care Products Market was valued at US$ 474.7 billion in FY 2021. It is projected to increase at a 4.0% annual pace in 2022 and close at US$ 496.63 billion. Moreover, growth is predicted to pick up speed at an astounding 4.62% CAGR during the evaluation period of 2022-2032 and reach US$ 780.16 billion.
With increased attention being paid to preventative healthcare in the aftermath…
Automatic Pet Feeder Market To Witness Exponential Growth, Expected to Hit US$ 1 …
The market for automatic pet feeders is expected to grow at a strong rate of 9.6% CAGR to reach US$ 1.36 billion by the end of 2032, from its estimated value of US$ 540.8 million in 2022.
By the end of 2021, sales of automatic pet feeders with capacities greater than five liters represented about 45% of the worldwide market for automatic pet feeders.
Download a Sample Copy Of Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=5963
Pet owners…
Tomato Powder Market Is Estimated To Reach US$ 2.3 Billion By The End Of 2033: F …
In 2023, the global market for tomato powder reached a valuation of US$ 1.6 billion. Projections indicate that by the close of 2033, sales of tomato powder on a global scale are expected to climb to US$ 2.3 billion, marking a compound annual growth rate (CAGR) of 3.7% from 2023 to 2033.
The Tomato Powder Industry sales study offers a comprehensive analysis on diverse features including production capacities, Tomato Powder demand,…
Portable Video Game Consoles Market Is Projected To Reach US$ 27 Billion By 2033 …
The forecast indicates a steady rise in global demand for portable video game consoles, projecting a Compound Annual Growth Rate (CAGR) of 6% from 2023 to 2033. Presently, the market for portable video game consoles stands at a valuation of US$ 15 billion globally. This figure is poised to ascend to US$ 27 billion by the conclusion of 2033.
The Portable Video Game Consoles Industry sales study offers a comprehensive analysis…
More Releases for Depression
Increase in the prevalence of anxiety disorders and depression is bolstering the …
The research report "Global Anxiety Disorders and Depression Treatment Market: By Product Type (MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics, Benzodiazepines, Anticonvulsants, Beta-Blockers, SRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), TeCAs (Tetracyclic Antidepressants), TCAs (Tricyclic Antidepressants), Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Others), and Geography- Global/Region/Country Forecast to 2028." The global anxiety disorders and depression treatment market size was valued at USD 8.2 Bn in the year…
Depression Treatment Device Market: Information by Product Type (Light Therapies …
Depression is characterized by multiple mental health challenges that involve a lack of positivity, suicidal thoughts, insomnia, anxiety, loss of appetite, and sadness. Depression is caused by a combination of biological, genetic, environmental, and psychological factors. Globally, the prevalence of depression is increasing at an alarming rate. About 300 million people of all ages suffered from depression and the suicide rate rose to about 8,00,000 individuals in 2018. As per…
Depression Cannot Hit A Moving Target
Cottonwood Heights, Utah, Mar 12, 2020 -- Depression can't hit a moving target. That was a phrase to live by for Chelsea Hansen. She was full of life and love, and she had big goals. But soon she was to discover that life doesn't turn out the way she planned.
Behind the Fake Smile is a fictional book based on real-life experiences. It's the story of how Chelsea navigates a world…
Depression Drugs Market: Increase in Cases of Depression to Boost Market Growth
Transparency Market Research (TMR) has published a new report titled, “Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global depression drugs market was valued at US$ 6,500 Mn in 2017 and is anticipated to decline at a CAGR of 2% from 2018 to 2026. The report suggests that rise in incidence of major depression disorders is projected to drive…
Depression Therapeutics Market Forecast till 2025
Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the brain exist in chemical form such as dopamine and serotonin, which are responsible for maintaining emotional balance such as mood and behavior. Antidepressants cover a wide range of drug categories, including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants…
Depression Drug Market: Global Depression Drug Forecast Will Reach $16.8 billion …
Zion Market Research has published a new report titled “Depression Drug (Benzodiazepines, SNRIs, TCAs, TeCAs, Atypical Antipsychotics, Monoamine Oxidase inhibitors and Others) Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020” According to the report, the global depression drug market was valued at USD 14.51 billion in 2014 and is expected to generate revenue of USD 16.8 billion by end of 2020, growing at a CAGR of 2.50%…
